Deuterated vortioxetine

氘代伏硫西汀

Report date: 2025/02/28 11:25:20
NME

Base Information

Drug NameDeuterated vortioxetine
Drug Alias NameJJH201501
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsSerotonin transporterDopamine transporterNorepinephrine transporter
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Giber Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Giber Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepressive Disorder
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A